Abstract: A portable vital statistics monitoring and medication dispensing system that provides personal healthcare management and daily prescription routines. The medication dispenser and vital statistics monitor combination incorporates a medication dispenser, a blood testing system, a pill cutting module operated by the control unit, and other vital sign monitoring into a portable wireless device with customizable features. The medication dispenser and vital statistics monitor combination has the capability of notifying the user of the correct times to take medication and automatically dispensing the accurate prescription dosage. The medication dispenser and vital statistics monitor combination communicates the patient information using an onboard display, transmits the information to a local or distributed network, or prints/embosses/etches the information onto patient information cards, wristbands, or other information sheets.

Abstract: A portable vital statistics monitoring and medication dispensing system that provides personal healthcare management and daily prescription routines. The medication dispenser and vital statistics monitor combination incorporates a medication dispenser, a blood testing system, and other vital sign monitoring into a portable wireless device with customizable features. The medication dispenser and vital statistics monitor combination has the capability of notifying the user of the correct times to take medication and automatically dispensing the accurate prescription dosage. The medication dispenser and vital statistics monitor combination communicates the patient information using an onboard display, transmits the information to a local or distributed network, or prints/embosses/etches the information onto patient information cards, wristbands, or other information sheets.

Abstract: The invention provides a synthetic bone precursor material comprising amorphous calcium phosphate and a constituent that inhibits the crystallisation of calcium hydroxyapatite to amorphous calcium phosphate. The synthetic bone precursor may comprise a material of formula CaxMgyPO4 wherein Mg acts as an inhibitor for crystallisation. Other crystallisation inhibitors such as pyrophosphate may be present. The inhibitor is capable of dissolving in physiological saline. Loss of inhibitor from the precursor allows crystallisation of hydroxyapatite. The invention relates to use of a synthetic bone precursor to form bone in vivo, by a transformation of the amorphous precursor material to crystalline hydroxyapatite bone material by the leaching action on inhibitory ions body fluids. it is envisaged that the material will be useful in facilitating bone repair, inducing bone formation or assisting in the attachment of prostheses.